Out-patient drug policy by clinical assessment rather than financial constraints?

• 1 September 2004
• journal article
• research article
• Published by Springer Nature in The European Journal of Health Economics
• Vol. 5  (3) , 274-277
• https://doi.org/10.1007/s10198-003-0223-0

Abstract

Keywords

• REIMBURSEMENT SYSTEM
• PHARMACEUTICAL REFERENCE PRICES
• OUT-PATIENT DRUG EXPENDITURES
• EFFICIENCY
• THERAPEUTIC VALUE
• BURDEN OF DISEASE